CIK 0001655759
- Accelerated filer
ARVINAS, INC.
Sign in to watch- Ticker
- ARVN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 472566120
- Phone
- +1 203-535-1456
- Business address
- 395 WINCHESTER AVE, 5 SCIENCE PARK, NEW HAVEN, CT, 06511
- Former names
- ARVINAS INC., ARVINAS HOLDING COMPANY, LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,475
- in 1 filing, $1K under 10b5-1 plans
Net −$1,475. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-03-02 | Houston John G President and CEO | Sale | −8,115 | $77.45 | $629K | 827,643 |
| 2021-03-02 | Houston John G President and CEO | Exercise or conversion · Restricted Stock Units | −17,510 | 35,021 | ||
| 2021-02-26 | Peck Ronald Chief Medical Officer | Grant or award · Stock Option (right to buy) | +68,000 | 0 | ||
| 2021-02-26 | Taylor Ian Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +68,000 | 0 | ||
| 2021-02-26 | Cassidy Sean A Chief Financial Officer | Grant or award · Stock Option (right to buy) | +68,000 | 0 | ||
| 2021-02-26 | Houston John G President and CEO | Grant or award · Stock Option (right to buy) | +219,500 | 0 | ||
| 2021-02-19 | Taylor Ian Chief Scientific Officer | Exercise or conversion | +6,456 | $16.00 | $103K | 76,854 |
| 2021-02-19 | Taylor Ian Chief Scientific Officer | Exercise or conversion · Stock Option (right to buy) | −704 | 596 | ||
| 2021-02-19 | Taylor Ian Chief Scientific Officer | Exercise or conversion · Stock Option (right to buy) | −2,437 | 9,211 | ||
| 2021-02-19 | Taylor Ian Chief Scientific Officer | Exercise or conversion · Stock Option (right to buy) | −3,315 | 27,345 | ||
| 2021-02-17 | Cassidy Sean A Chief Financial Officer | Exercise or conversion | +325 | $16.00 | $5K | 155,109 |
| 2021-02-17 | Cassidy Sean A Chief Financial Officer | Exercise or conversion | +569 | $16.00 | $9K | 155,678 |
| 2021-02-17 | Cassidy Sean A Chief Financial Officer | Exercise or conversion · Stock Option (right to buy) | −325 | 1,192 | ||
| 2021-02-17 | Cassidy Sean A Chief Financial Officer | Exercise or conversion · Stock Option (right to buy) | −569 | 22,127 | ||
| 2021-02-16 | Houston John G President and CEO | Exercise or conversion | +1,560 | $16.00 | $25K | 817,760 |
| 2021-02-16 | Houston John G President and CEO | Exercise or conversion · Stock Option (right to buy) | −1,560 | 87,320 | ||
| 2021-02-16 | Houston John G President and CEO | Exercise or conversion | +44,000 | $16.00 | $704K | 860,000 |
| 2021-02-16 | Houston John G President and CEO | Sale | −8,928 | $77.62 | $693K | 851,272 |
| 2021-02-16 | Houston John G President and CEO | Sale | −21,249 | $78.66 | $1.7M | 830,023 |
| 2021-02-16 | Houston John G President and CEO | Sale | −13,223 | $79.72 | $1.1M | 816,800 |
Page 20 of 32 · 628 trades